Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02333162
Title Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

hematologic cancer

bone marrow cancer

acute myeloid leukemia

Therapies

Mycophenolate mofetil

Tacrolimus

Fludarabine + Melphalan

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.